LOGO
LOGO

Intraday Alerts

Neuronetics Stock Rises 7% Despite Wider-Than-Expected Q3 Loss

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us

Neuronetics, Inc. (STIM) shares rose 7.22 percent to $2.97 on Tuesday's trading after the company reported a smaller loss for the third quarter than last year.

The company posted a net loss of $9.05 million, or $0.13 per share, compared with a loss of $13.34 million, or $0.44 per share, a year earlier. Analysts had expected a loss of $0.12 per share. Revenue surged 101.3 percent, to $37.3 million from $18.53 million last year.

The stock opened at $2.38 and traded between $2.38 and $3.09 during the session on the Nasdaq. It was last seen at $2.60 compared with a previous close of $2.77. Trading volume stood at about 3 million shares, higher than the average of 1.4 million.

Neuronetics shares have traded between $0.52 and $5.92 over the past 52 weeks.

For comments and feedback contact: editorial@rttnews.com

Business News

Get Access to Premium Stock Alerts with RTT Biotech Investor.
Global Economics Weekly Update -June 15 - June 19, 2026

June 19, 2026 16:46 ET
Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.